- As the biology of mesenchymal stromal cells (MSCs) in patients with non-malignant hematological diseases (NMHD) is poorly understood, in the current study we performed a basic characterization of the phenotype and functional activity of NMHD-MSCs. Bone marrow (BM) of patients with thalassemia major (TM) possessed a significantly higher number of nucleated cells (BM-MNCs)/mL BM than healthy donors (P < 0.0001), which however did not result in a higher number of colony forming units-fibroblast (CFU-F) per milliliter BM. In contrast, from 1 × 106 BM-MNCs of patients with sickle cell disease (SCD) were generated significantly more CFU-Fs than from TM-BM-MNCs (P < 0.013) and control group (P < 0.02). In addition, NMHD-MSCs expressed significantly lower levels of CD146 molecule, demonstrated an equal proliferation potential and differentiated along three lineages (osteoblasts, chondrocytes and adipocytes) as healthy donors’ MSCs, with exception of TM-MSCs which differentiated weakly in adipocytes. In contrast to other NMHD-MSCs and healthy donors’ MSCs, TM-MSCs demonstrated an impaired in vitro immunosuppressive potential, either. Noteworthy, the majority of the immunosuppressive effect of NMHD-MSCs was mediated through prostaglandin-E2 (PGE2), because indomethacin (an inhibitor of PGE2 synthesis) was able to significantly reverse this effect. Our results indicate therefore that NMHD-MSCs, except TM-MSCs, may be used as an autologous cell-based therapy for post-transplant complications such as graft failure, graft-versus-host disease (GvHD) and osteonecrosis.
MetadatenVerfasserangaben: | Zyrafete KuçiGND, Christiane Jordan, Sibylle Wehner, Jan SörensenGND, Andrea JarischORCiDGND, Emilia Salzmann-Manrique, Lisa-Marie PfeffermannGND, Thomas KlingebielORCiDGND, Peter BaderORCiDGND, Selim KuçiORCiDGND |
---|
URN: | urn:nbn:de:hebis:30:3-544229 |
---|
DOI: | https://doi.org/10.3390/cells9020431 |
---|
Pubmed-Id: | https://pubmed.ncbi.nlm.nih.gov/32059574 |
---|
Titel des übergeordneten Werkes (Englisch): | Cells |
---|
Verlag: | MDPI |
---|
Verlagsort: | Basel |
---|
Dokumentart: | Wissenschaftlicher Artikel |
---|
Sprache: | Englisch |
---|
Datum der Veröffentlichung (online): | 12.02.2020 |
---|
Datum der Erstveröffentlichung: | 12.02.2020 |
---|
Veröffentlichende Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Datum der Freischaltung: | 08.04.2020 |
---|
Freies Schlagwort / Tag: | mesenchymal stromal cells; non-malignant hematological diseases; severe congenital neutropenia; sickle cell anemia; thalassemia |
---|
Jahrgang: | 9 |
---|
Ausgabe / Heft: | 431 |
---|
Bemerkung: | This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
---|
HeBIS-PPN: | 463771974 |
---|
Institute: | Medizin / Medizin |
---|
DDC-Klassifikation: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Open-Access-Publikationsfonds: | Medizin |
---|
Lizenz (Deutsch): | Creative Commons - Namensnennung 4.0 |
---|